Navidea aims to get European clearance for Lymphoseek

02/1/2012 | Business Wire

Navidea Biopharmaceuticals says it will submit a marketing authorization application in the European Union for Lymphoseek following advice from regulators that the drug qualifies for the filing. The company will pursue permission for the use of Lymphoseek in intraoperative lymphatic mapping and lymphoscintigraphy imaging.

View Full Article in:

Business Wire

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN